Archives: Publications

• Donovan CM, Buffini M, Walton J, Kehoe L, Kearney J, Flynn A, Nugent A, McNulty B. Trends in the weight status of adults in Ireland between 1990 and 2024 Eur J Nutr

• Wharton S, le Roux CW, Bozkurt B, Platz E, Bleckert G, Ajaz Hussain S, Brueckmann M, Startseva E, Kloer IM, Kaplan LM. Baseline characteristics in the SYNCHRONIZE™-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes Diabetes Obes Metab

• Pandey A, Moroney M, Verma S, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Shah SJ, Petrie MC, Rönnbäck C, Domdey A, Rasmussen S, Chinnakondepalli KM, Patel S, Kosiborod MN. Effects of semaglutide in obesity-related heart failure with preserved ejection fraction across the age spectrum: Findings from the STEP-HFpEF programme Eur J Heart Fail

• Mondoh A, Crotty M, le Roux CW. Tirzepatide vs. semaglutide: clinical decision-making in the GLP-1 landscape Expert Opin Pharmacother

• Drews-Botsch C, Harrington S. Obesity and physical activity in children with early vision problems: a secondary analysis of data from the Growing-Up in Ireland study BMC Pediatr

• Platz E, Kaplan LM, le Roux CW, Wharton S, Burger S, Hussain SA, Brueckmann M, Startseva E, Fey C, Kosiborod MN, Bozkurt B. Survodutide for the Treatment of Obesity: Baseline Characteristics of the SYNCHRONIZE Cardiovascular Outcomes Trial JACC Heart Fail

  Chronic Kidney Disesae

• Monzo L, Savarese G, Mullens W, Abdin A, Bozkurt B, Chioncel O, El Hadidi S, Gorter TM, Inciardi RM, Petrie MC, Schiattarella GG, Stolfo D, Metra M, Girerd N. Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus document Eur J Heart Fail

• Sherifali D, Racey M, Fitzpatrick-Lewis D, Greenway M, Sockalingam S, Wada J, Teoh SH, Patton I, Macklin D, van Rossum EFC, Busetto L, Horn DB, Patricia Nece JD, Leguede MEGS, Pearce N, Le Roux C, Ard J, Alberga AS, Kaplan L, Sharma AM, Wharton S. Missing the Target: A Scoping Review of the Use of Percent Weight Loss for Obesity Management Obes Rev

• Giblin, Kaplan, Somers, Le Roux, Hunter, Wu, Lalonde, Ahmad, Bethel Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials Diabetes, Obesity and Metabolism

• Son JW, le Roux CW, Blüher M, Nauck MA, Lim S. Novel GLP-1-Based Medications for Type 2 Diabetes and Obesity Endocr Rev

  Insulin Resistance & Diabetes